Related Experiment Video
Updated: Jul 12, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction
Jeanie F Kincer1, Annette Uittenbogaard, James Dressman
1University of Kentucky Medical School, Department of Physiology, Lexington, Kentucky 40536, USA.
Insights
CD36 absence prevents hypercholesterolemia-induced hypertension by maintaining nitric oxide generation and vasodilation. This study links CD36 to hypertension development and nitric oxide synthase function.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Hypertension Research
Background:
- Hypertension is linked to CD36 presence/absence.
- Hypercholesterolemia impairs nitric oxide-induced vasodilation, increasing blood pressure.
Purpose of the Study:
- To test if diet-induced hypercholesterolemia disrupts nitric oxide generation and vasodilation in a CD36-dependent manner.
- To investigate the role of CD36 in hypercholesterolemia-mediated vascular dysfunction.
Main Methods:
- Mice models (C57BL/6, apoE null, CD36 null, apoE/CD36 null) were fed chow or high-fat diets.
- Vascular responsiveness to acetylcholine was measured.
- Caveolae integrity and endothelial nitric-oxide synthase localization were analyzed.
- Low-density lipoprotein (LDL) fraction and cyclodextrin effects were examined.
Main Results:
- ApoE null mice on high-fat diet lost acetylcholine-induced vasodilation; CD36 null mice did not.
- High-fat diet depleted caveolae of cholesterol and endothelial nitric-oxide synthase in apoE null mice.
- Plasma LDL fraction and cyclodextrin mimicked these effects, impairing nitric oxide production.
Conclusions:
- Ablation of CD36 prevents hypercholesterolemia's negative impact on nitric oxide-mediated vasodilation.
- CD36 is directly linked to early events in hypercholesterolemia-induced hypertension.
- Mechanisms involve CD36, nitric oxide synthase, caveolae integrity, and blood pressure regulation.
Abstract:
Numerous studies have implicated either the presence or absence of CD36 in the development of hypertension. In addition, hypercholesterolemia is associated with the loss of nitric oxide-induced vasodilation and the subsequent increase in blood pressure. In the current study, we tested the hypothesis that diet-induced hypercholesterolemia promotes the disruption of agonist-stimulated nitric oxide generation and vasodilation in a CD36-dependent manner. To test this, C57BL/6, apoE null, CD36 null, and apoE/CD36 null mice were maintained on chow or high fat diets. In contrast to apoE null mice fed a chow diet, apoE null mice fed a high fat diet did not respond to acetylcholine with a decrease in blood pressure. Caveolae isolated from in vivo vessels did not contain endothelial nitric-oxide synthase and were depleted of cholesterol. Age-matched apoE/CD36 null mice fed a chow or high fat diet responded to acetylcholine with a decrease in blood pressure. The mechanism underlying the vascular dysfunction was reversible because vessels isolated from apoE null high fat-fed mice regained responsiveness to acetylcholine when incubated with plasma obtained from chow-fed mice. Further analysis demonstrated that the plasma low density lipoprotein fraction was responsible for depleting caveolae of cholesterol, removing endothelial nitric-oxide synthase from caveolae, and preventing nitric oxide production. In addition, the pharmacological removal of caveola cholesterol with cyclodextrin mimicked the effects caused by the low density lipoprotein fraction. We conclude that the ablation of CD36 prevented the negative impact of hypercholesterolemia on agonist-stimulated nitric oxide-mediated vasodilation in apoE null mice. These studies provide a direct link between CD36 and the early events that underlie hypercholesterolemia-mediated hypertension and mechanistic linkages between CD36 function, nitric-oxide synthase activation, caveolae integrity, and blood pressure regulation.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Atherosclerosis III: Management

